{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:28:03Z","timestamp":1791419283657,"version":"4.3.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa827010"],"award-info":[{"award-number":["JP243fa827010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa827010"],"award-info":[{"award-number":["JP243fa827010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-024-00988-9","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:03:21Z","timestamp":1728918201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection"],"prefix":"10.1038","volume":"9","author":[{"given":"Shiho","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-1922","authenticated-orcid":false,"given":"Ryuta","family":"Uraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-020X","authenticated-orcid":false,"given":"Kiyoko","family":"Iwatsuki-Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","unstructured":"Verhagen, J. H., Fouchier, R. A. M. & Lewis, N. Highly Pathogenic Avian Influenza Viruses at the Wild-Domestic Bird Interface in Europe: Future Directions for Research and Surveillance. Viruses 13 https:\/\/doi.org\/10.3390\/v13020212 (2021).","DOI":"10.3390\/v13020212"},{"key":"988_CR2","doi-asserted-by":"publisher","unstructured":"Graziosi, G., Lupini, C., Catelli, E. & Carnaccini, S. Highly Pathogenic Avian Influenza (HPAI) H5 Clade 2.3.4.4b Virus Infection in Birds and Mammals. Animals (Basel) 14 https:\/\/doi.org\/10.3390\/ani14091372 (2024).","DOI":"10.3390\/ani14091372"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3201\/eid2806.212246","volume":"28","author":"V Potdar","year":"2022","unstructured":"Potdar, V. et al. Identification of Human Case of Avian Influenza A(H5N1) Infection, India. Emerg. Infect. Dis. 28, 1269\u20131273 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00705-024-06032-4","volume":"169","author":"DS Tare","year":"2024","unstructured":"Tare, D. S., Keng, S. S., Walimbe, A. M. & Pawar, S. D. Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021. Arch. Virol. 169, 111 (2024).","journal-title":"Arch. Virol."},{"key":"988_CR5","doi-asserted-by":"publisher","unstructured":"Guan, L. et al. Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets. Viruses 15 https:\/\/doi.org\/10.3390\/v15051093 (2023).","DOI":"10.3390\/v15051093"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3389\/fmicb.2019.01411","volume":"10","author":"G Zhong","year":"2019","unstructured":"Zhong, G. et al. Isolation of Highly Pathogenic H5N1 Influenza Viruses in 2009-2013 in Vietnam. Front Microbiol 10, 1411 (2019).","journal-title":"Front Microbiol"},{"key":"988_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2244091","volume":"12","author":"P Chang","year":"2023","unstructured":"Chang, P. et al. Characterization of the haemagglutinin properties of the H5N1 avian influenza virus that caused human infections in Cambodia. Emerg. Microbes Infect. 12, 2244091 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"988_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48555-z","volume":"15","author":"C Furey","year":"2024","unstructured":"Furey, C. et al. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Nat. Commun. 15, 4350 (2024).","journal-title":"Nat. Commun."},{"key":"988_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00932-x","volume":"9","author":"X Cui","year":"2024","unstructured":"Cui, X. et al. Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza. NPJ Vaccines 9, 138 (2024).","journal-title":"NPJ Vaccines"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/mlf2.12085","volume":"2","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Protective efficacy of a universal influenza mRNA vaccine against the challenge of H1 and H5 influenza A viruses in mice. mLife 2, 308\u2013316 (2023).","journal-title":"mLife"},{"key":"988_CR11","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00988-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:07:23Z","timestamp":1728918443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1038\/s41541-024-00988-9","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.Y., K.S., Y.O., A.Y., T.M., and F.T. are employees of Daiichi Sankyo Co., Ltd. Y.K. has received unrelated funding support from FUJIFILM Toyama Chemical Co., Ltd.; TAUNS Laboratories, Inc.; Shionogi & Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; KM Biologics Co., Ltd.; Kyoritsu Seiyaku Corporation; Shinwa Corporation; and Fujirebio Diagnostics. Y.K. is also a co-founder of FluGen, Inc. Y.K. is supported by grants from the Japan Program for Infectious Diseases Research and Infrastructure (JP24wm0125002) and the Japan Initiative for World-leading Vaccine Research and Development Centers (JP243fa627001) from Japan Agency for Medical Research and Development (AMED). Y.K. and Daiichi Sankyo Co., Ltd. are also supported by the Program on R&D of new generation vaccine including new modality application (JP243fa827010) from AMED. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}